Cohort analysis in the context of clinical genomics variant interpretation
As genetic testing is being proven useful and used in ever more areas of medicine where it can instruct disease prevention, medical care, and
PRESS RELEASE | Euformatics, Oncompass Medicine and Institut Curie awarded Eurostars funding to develop an oncology solution with genomic noise canceling
Espoo, Finland, September 12th, 2023. Euformatics has partnered with Oncompass Medicine from Hungary and Institut Curie from France and submitted a
PRESS RELEASE | Euformatics partners with Cerba to provide software tools for clinical genomic data analysis
Espoo, Finland, September 6th, 2023. Euformatics, a world leader in NGS quality control and variant interpretation tools, announced that it has
PRESS RELEASE | Euformatics partners with Appolon Bioteck to expand in the French market
Espoo, September 6th, 2023. Euformatics, a Finnish bioinformatics company that develops world-leading genomic data analysis tools, announced that it
CNV analysis with Euformatics Genomics Hub
Copy Number Variations (CNVs) refer to alterations in the DNA of a genome that result in cells having an abnormal number of copies of one or more
PRESS RELEASE | Euformatics expands in the Middle East in partnership with Zahrawi Medical Group for Bahrain, Oman and the UAE markets
Espoo, Finland, May 2023. Euformatics, a Finnish bioinformatics company that develops world-leading NGS interpretation and quality control tools,
Streamlining NGS Testing: A Modular Solution with Euformatics Genomics Hub
Automation is a critical component of NGS testing and Euformatics Genomics Hub is leading the way with innovative solutions. With an ever-increasing